Designing for clinical trust: how UI/UX governance affects AI adoption in healthcare

This scenario plays out thousands of times daily across health systems worldwide, revealing something many product teams overlook. The thing is, trust in healthcare AI is shaped less by model accuracy and more by how that accuracy is presented. This post discusses why an effective UI/UX governance model is the missing layer between creating a technologically robust AI product and one that clinicians will actually use in their daily practice.

Why trust in healthcare AI defaults to the interface

Studies show that when AI is more transparent, clinicians are far more likely to accept its recommendations — while opaque systems are often ignored. Same AI model, different interfaces, vastly different outcomes. In practice, physicians don’t evaluate F1 scores or training data. They see a recommendation on a screen and decide within seconds whether to trust it or override it.

The research supports this model. A scoping review published in Frontiers in Health Services indicates that trust is largely shaped by user-facing perception and experience, not deep technical understanding. Only two studies included in the review evaluated trust on a relational basis (i.e., not evaluating the technology itself but rather the relationship to people and systems associated with it).

That distinction matters enormously for product teams. Because it means building trust in healthcare AI requires designing the relationship between the clinician and the tool, and that relationship lives entirely in the interface. Think about the last time you used an unfamiliar medical device. Did you read the technical manual first? Probably not. You looked at the screen, tried to understand the controls, and made a judgment call about whether you could rely on it. Clinicians do the same with AI tools. The difference is that their judgment call affects patient outcomes.

{{banner}}

Where most AI health products fail

The primary focus of AI governance in the healthcare sector is adherence to regulations. Teams spend months setting up HIPAA frameworks, navigating FDA approval paths, and handling data residency requirements. This type of governance is important and necessary, but it answers one key question only: “Can we legally implement this?” Architectural governance answers the other key question: “Will people actually use any of this once it’s released?”

And right now, many teams skip the second question. A 2025 analysis in npj Digital Medicine of over 1,000 FDA-cleared AI devices found that most fail to disclose key details such as training data sources, dataset size, and performance metrics. If the manufacturers themselves aren’t disclosing this, imagine what the interface communicates to the clinician using the tool: nothing.

A 2025 World Economic Forum report notes that current healthcare evaluation frameworks were designed for static systems like drugs and medical devices, and are not well-suited to AI systems that continuously evolve after deployment. As such, governance of AI will require a new paradigm that undergoes continuous evaluation rather than being merely a “one-time” verification of compliance.

What design governance actually looks like

The governance of AI health product design is an organized process that is repeated many times. It is a collection of standards and processes for reviewing all interface elements to ensure they communicate confidence, responsibility, and appropriate clinical reasoning to users. Design governance will include the following:

• Explainability standards. AMA surveys show that about two-thirds of physicians see value in AI tools, and that trust depends heavily on oversight, transparency, and clinician control. AI recommendations must show clear explanations directly in the main workflow, not hidden in links or tooltips. Easy access to oversight builds clinician trust and usability.
• Confidence statements. A percentage alone isn’t enough. Confidence scores should include context, benchmarks, and clear guidance on what to do when uncertainty is high. For example, if the AI gives a clinician a “92% confidence” statement, the statement does not provide adequate information to the clinician (e.g., scan x-ray data comparing results of all radiologists who reviewed the x-ray data). 
• Override architecture. Clinicians must always be able to override AI suggestions, with overrides recorded. This supports control, accountability, and trust in the system. When the AI system demonstrates respect for the clinician’s authority, the clinician will have greater trust in it.
• Audit trail visibility. Clinicians should easily see why a recommendation was made, what data it used, and when the model was last updated — without leaving their workflow. 

Four pillars of trust in healthcare AI interface design

Having built healthcare products across telehealth, clinical decision support, and patient-facing tools, we’ve distilled what actually works into clear design pillars. Below, you’ll find out the reasons that directly shape whether clinicians trust or ignore AI recommendations.

1. Contextual explainability

Transparency and explainability are often treated as the same, but they are not. Transparency is about exposing how the system works; explainability is about making that information usable in real decisions. A full list of model weights may be transparent, but it isn’t helpful. A clear statement like “this recommendation is based on elevated CRP levels and recent imaging history” turns that information into something a clinician can actually act on.

For instance, Singapore General Hospital’s AI2D model achieved 90% accuracy in early validations. But the reason clinicians adopted it was not the accuracy. It was the contextual explainability. The system uses real-time patient data and explains its reasoning in clinical terms that the treating physician already understands. For product teams, this means: the explainability layer cannot be an afterthought bolted onto a data science output.

2. Progressive disclosure of AI confidence

Different clinical decisions require varying amounts of information to support the decision. For example, a standard triage suggestion will require less background information than a cancer screening flag.

To facilitate effective trust-building, different tiers of confidence communication are created through design governance:

• Tier 1: Glanceable trust. It includes easy-to-read visual status indicators (green, amber, red, or a confidence bar) that any independent clinician can determine in less than 2 seconds during busy shift times.
• Tier 2: Supporting context. In essence, one click/tap or hover will provide additional information about supporting the recommendation (e.g., patient history, relevant biomarkers, similar case comparisons).‍
• Tier 3: Full audit. It means creating a complete panel of all information related to the generation of the recommendation. Among its elements are model version, training data, last validation date, and a method for flagging for review.

This tiered structure adequately respects clinicians’ time constraints while still allowing full accountability for the recommendations made. Many current health AI products are structured with all the information at tier 3 and none at tier 1; this is reversed, as the decision to establish trust typically occurs at the glanceable level.

“The glanceable trust layer is where clinicians decide to follow or override an AI recommendation. Get that wrong, and the deeper layers never get opened.”

3. Human-in-the-loop architecture as a design pattern

The term “Human in the loop” appears frequently in AI ethics literature, but little attention is paid to its design aspects. In practice, this means that an interface should provide human oversight in a manner perceived as natural rather than bureaucratic. Let’s take a look at two examples of poor vs. good implementations:

• Poor: A “modal” dialog that forces a clinician to accept or deny every AI suggestion prior to moving forward. ‍
• Good: An ambient system in which AI-generated recommendations are added to existing clinician workflows without extra steps required for override. Such a system learns from overridden suggestions in order to offer better recommendations in the future.

When building AI trust in the healthcare industry, the interface should position the clinician as the final authority while making the AI’s contribution visible enough to be useful. This is a UX challenge, not an algorithm challenge. And it is where most clinical AI products lose their users.

4. Embedded feedback loops

The final pillar of trust is a feedback system that lets clinicians rate AI suggestions and leave comments directly in the interface, in real time. These comments are added to the ongoing model-improvement process, but, most importantly, they tell the healthcare provider that their assessment is relevant to this particular model.

Researchers at CU Anschutz are developing tools such as MUSE to help clinicians determine when to trust AI predictions and when to be skeptical. The insight: trust calibration, or knowing how much to trust, is more valuable than blanket trust or blanket skepticism. Feedback loops in the interface help clinicians develop that calibration over time.

Measuring trust in healthcare AI through design metrics

If you cannot measure it, you cannot govern it. Design governance requires trust-specific metrics that sit alongside traditional product analytics. Here are three we track on healthcare AI projects:

• Override rate by interface context. If overrides cluster at a specific screen or recommendation type, that is a design signal, not a model signal. Evidence from healthcare AI studies shows a substantial reduction in clinician override rates when AI outputs are made transparent and interpretable, compared to opaque systems. That gap is closed by design, not retraining.
• Time-to-decision per AI recommendation. When clinicians trust the interface, decision time drops. When they do not, they either slow down (seeking more context) or skip past (ignoring the recommendation entirely). Both patterns are measurable and actionable.
• Explainability engagement rate. How often do clinicians expand the Tier 2 and Tier 3 explainability panels? Low engagement does not necessarily mean low trust. It might mean Tier 1 is working well. But tracking this over time reveals whether trust is deepening or stagnating.

A practical UI/UX governance framework for AI health products

Ideas are helpful, but frameworks are what actually get products built. Here’s a governance model that teams can start using this quarter without a regulatory consultant.

Phase 1: Trust audit of existing interfaces

Before you create features that are new to an application, review the function of the feature as it is used in your application. Go to every screen where AI recommendations are displayed and ask yourself: “Is the clinician able to understand the reasons for the recommendation?” “Is it possible for the clinician to override the recommendation without any barriers?” “Can the clinician see the time at which the recommendation was last validated?” If any of these questions result in a negative answer, this becomes your starting point to improve the interface’s trust.

Halo Lab conducts UX audits specifically to identify usability gaps related to trust between the clinician and the technology within the clinical interface. The results of these audits are often surprising to product teams. A hidden disclaimer, an unclear score, or the lack of a timestamp can all create trust issues that will not become evident through standard usability testing.

Phase 2: Establish explainability standards

Document what every AI output must show at each tier. Create a design pattern library for trust elements: confidence indicators, data provenance badges, model version labels, override buttons. Standardize these across your product so clinicians can develop a consistent mental model.

This is where healthcare UX trends are heading in 2026. Ethics and trust are becoming the determining factors as AI becomes a vital part of clinical workflows. Products that establish these standards now will have a structural advantage later.

Phase 3: Implement trust metrics

Capture override rates, decision timestamps, and engagement to provide patients with information explaining why something is being done. Create a trust dashboard to track these metrics and review them monthly alongside clinical outcomes data. If trust metrics decrease, first assess your application’s design, not the model.

Phase 4: Continuous trust testing

Each quarter, run usability studies focused specifically on trust, separate from standard task-based testing. In these studies, clinicians are shown AI recommendations, and their reactions are observed, including how much they trust the output, what additional context they rely on, and whether they choose to override it. The studies should also track how changes in the interface influence these behaviors.

What clinicians actually need from AI interfaces — and what they get instead

This is where a key industry gap becomes obvious. Product teams often design AI features for demos, while clinicians need them for real clinical pressure — like a 3 a.m. shift.

A nurse in a busy emergency department doesn’t have time to interpret complex explainability dashboards. They need a simple, immediate recommendation with a clear next step. A specialist reviewing a pathology report, on the other hand, may want detailed context, but only after forming an initial judgment. If the AI output appears too early, it can bias their thinking; if it appears too late, it adds little value.

This timing problem is a design problem. And solving it requires understanding clinical workflow design at the level of specific roles, shift patterns, and decision contexts. We see this consistently in our product design practice: healthcare AI products that test beautifully in controlled environments collapse under real clinical conditions. The fix is almost never a model improvement. It is a workflow redesign that accounts for the cognitive load, time pressure, and interpersonal dynamics of actual clinical settings.

Building patient-facing trust in healthcare AI

Most discussions about building trust in healthcare AI focus exclusively on clinicians. But patients are stakeholders too, and their trust dynamics are entirely different.

Generally, patients trust AI as a backstage tool but not as a front-stage actor. Interface design must respect this boundary. Patients don’t care about model versions — they care about whether a human oversees the AI, if they can ask questions, and who has access to their data. Thus, you should check out:

• clear consent flows;
• indicators that there is human oversight; 
• communicating in plain language the function(s) of the AI; 
• showing clearly what the AI does not do.

Results from our telemedicine platform projects have consistently shown that when the patient interface clearly conveys the role of the human physician in the patient’s care process, patient trust in the system is significantly improved, without disclosing any technical architectural information.

{{banner-2}}

Trust is a design deliverable

If teams treat trust as something they have to design — with clear metrics, testing, and strong review processes — they’ll build healthcare AI people actually use. Otherwise, even highly accurate tools risk being ignored. At Halo Lab, we have been designing for healthcare since our early telemedicine projects. We have seen firsthand how a single interface decision can shift adoption from resistance to routine. For this, you should make trust a feature, not an afterthought.